Position in BMY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$125,428,081
+$42,062,247 QoQ
Shares Held
2,068,064
+33.8% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Dec 31, 2022CallValue
$2,878,000
CallShares
40,000
PutValue
$4,396,145
PutShares
61,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NATIXIS holds $547,855,762 across 11 Drug Manufacturers - General names. BMY ranks #1 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
This page
|
2,068,064 | $125,428,081 | |
| 2 | LLY |
ELI LILLY & Co
|
100,947 | $92,848,022 | |
| 3 | NVO |
Novo Nordisk A S
|
2,005,285 | $73,694,223 | |
| 4 | MRK |
Merck & Co., Inc.
|
510,056 | $61,354,636 | |
| 5 | PFE |
Pfizer Inc
|
1,912,234 | $53,695,530 | |
| 6 | JNJ |
Johnson & Johnson
|
213,825 | $52,267,383 | |
| 7 | ABBV |
AbbVie Inc.
|
233,196 | $50,717,798 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
156,715 | $21,841,369 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $125,428,081 | 2,068,064 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $83,365,834 | 1,545,529 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $31,008,775 | 687,556 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $16,589,965 | 358,392 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $25,011,633 | 410,094 | Shares | Sole | 2025-07-18 | |
| 2024-12-31 | $70,409,055 | 1,244,856 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $70,046,284 | 1,353,813 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $66,195,954 | 1,593,931 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $8,129,607 | 158,441 | Shares | Sole | 2024-02-13 | |
| 2023-06-30 | $83,054,103 | 1,298,735 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $30,758,045 | 443,775 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,396,145 | 61,100 | Put | Sole | 2023-02-24 | |
| 2022-12-31 | $2,878,000 | 40,000 | Call | Sole | 2023-02-24 | |
| 2022-12-31 | $99,566,928 | 1,383,835 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $425,497,891 | 5,985,341 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $2,843,600 | 40,000 | Call | Sole | 2022-11-14 | |
| 2022-06-30 | $437,204,460 | 5,677,980 | Shares | Sole | 2022-08-12 | |
| 2022-06-30 | $3,080,000 | 40,000 | Call | Sole | 2022-08-12 | |
| 2022-03-31 | $57,897,891 | 792,796 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $50,775,095 | 814,356 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $25,062,458 | 423,567 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $59,956,917 | 897,290 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $69,842,486 | 1,106,328 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $79,560,793 | 1,282,618 | Shares | Defined | 2021-02-12 | |
| 2020-06-30 | $61,860,481 | 1,052,049 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $83,205,438 | 1,492,742 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||